Drawing for Serial No. 79278164

USPTO serial 79278164

Serial No. 79278164

Reviewed by CopyMark Law Group

Reg. 6187324Status 739Renewal
Filing date
Status date
Registration date
Nov 3, 2020
Examiner
BUKER, RACHEL EVE
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with Serial No. 79278164?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Hardin, Esq.

Peter J. Hardin, Esq. Dentons Sirote PC2311 Highland Ave. S.Birmingham, AL 35205United States

Goods and services

ClassDescriptionStatusFirst use
035Business management and business administration services, in the field of medical care network and research operations in the field of inflammation medicine; organization and arrangement of exhibitions and trade fairs for commercial and advertising purposes; marketing services and public relations; distribution of advertising material; procurement services, namely, procurement of service contracts for othersACTIVE—
041Educational and training services, in particular, arranging and conducting of seminars and workshops and programs for young academics in the fields of science, medicineACTIVE—
042Scientific services and research activities, in particular, scientific and medical research, namely, medical, clinical and interdisciplinary research in the field of inflammation medicine, including fundamental research, contract research and clinical studies; scientific and medical research, namely, development and application of new therapies and therapy approaches and diagnostic methods in the field of chronic inflammatory diseases for scientific purposes; scientific research, namely, scientific reports and surveys; industrial analyses and research services, namely, conducting clinical studies and technical project studies in the field of high-throughput of molecular diagnostics, and translational and clinical research based on molecular makeup of patientsACTIVE—
044Medical services, in particular, medical and clinical analyses for diagnostic and treatment purposes; Medical care, namely, therapeutical and medical treatment and attendance in the nature of medical care services in inflammation medicine and for inflammation related conditions and comorbidities; services of a hospital being hospital services; medical careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Oct 22, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Oct 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 22, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 3, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 28, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 19, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 18, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 3, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 4, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 3, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 4, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 4, 2020RFRRREFUSAL PROCESSED BY MPU—
Feb 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 12, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2020DOCKASSIGNED TO EXAMINER—
Feb 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance